Olema Pharmaceuticals Banner Image

Olema Pharmaceuticals

  • Ticker OLMA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Olema Pharmaceuticals Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema recently initiated a Phase 1/2 dose-escalationMore and expansion clinical trial of OP-1250. They are supported in their mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies.
5.0 / 5.0 (1)

Olema Pharmaceuticals reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Olema Pharmaceuticals

Most Recent Annual Report

Olema Pharmaceuticals
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Olema Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!